RSK1/2/3/4 (Phospho-Ser221/227/S218/232) Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-RSK1/2/3/4 (Phospho-Ser221/227/S218/232) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | RSK1/2/3/4 (Phospho-Ser221/227/S218/232) |
| Clone | polyclonal |
| Host Species | n/a |
| Reactive Species | human, mouse |
| Isotype | n/a |
| Format | epitope affinity purified |
| Size | 0.1 mg |
| Concentration | n/a |
| Applications | Western Blot (WB), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: RSK1/2/3/4 (Phospho-Ser221/227/218/232) antibody detects endogenous levels of RSK1/2/3/4 only when phosphorylated at serine 221/227/218/232. |
| Immunogen | Immunogen: The antiserum was produced against synthesized phosphopeptide derived from human RSK1/2/3/4 around the phosphorylation site of serine 221/227/218/232 (A-Y-SP-F-C). |
| Other Names | [90 kDa ribosomal protein S6 kinase 1; EC 2.7.11.1; kinase p90RSK1; KS6A1; KS6AA; MAPKAP-K1a; p90-RSK 1; pp90RSK1; Ribosomal protein S6 kinase alpha 1; Ribosomal S6 kinase 1; RPS6KA1; RSK-1; RSK1; S6K-alpha 1], [RPS6KA1; RPS6KA1; RSK; HU-1; RSK1; p90Rsk; MAPKAPK1A; MAPKAPK1A; RSK1; S6K-alpha-1; p90-RSK 1; p90RSK1; p90S6K; MAPK-activated protein kinase 1a; MAPKAP kinase 1a; MAPKAPK-1a; RSK-1] |
| Gene, Accession # | [RSK1/2/3/4], Gene ID: 6195, NCBI: NP_001006666.1, UniProt: Q15418 |
| Catalog # | MBS855061 |
| Price | $280 |
| Order / More Info | RSK1/2/3/4 (Phospho-Ser221/227/S218/232) Antibody from MYBIOSOURCE INC. |
| Product Specific References | Moller D.E., Am. J. Physiol. 266:C351-C359(1994). Gregory S.G., Nature 441:315-321(2006). The MGC Project Team, Genome Res. 14:2121-2127(2004). |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies